Skip to content
Cardiovascular healthResearch article4 min read

Diet-replacement weight loss: blood pressure fell, but some needed medicines restarted

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). · Diabetologia · 2021 · Original paper ↗

Key takeaway

In the DiRECT diet-replacement arm, 65 of 78 people treated for hypertension stopped all blood pressure medicines per protocol and mean blood pressure fell, yet 19 of the 69 who stopped had medicines restarted. This is a post hoc analysis of one trial arm with no comparison group, run under close monitoring.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Rapid weight loss can lower blood pressure, which raises the question of what to do with blood pressure medicines taken during a very low-energy diet. The authors evaluated the safety and efficacy of a planned withdrawal of all antihypertensive and diuretic medicines at the start of a formula low-energy diet replacement aimed at remission of type 2 diabetes.

Who and how

Post hoc analysis of the intervention arm of the Diabetes Remission Clinical Trial (DiRECT; n = 143), and of the subset (n = 69) who stopped antihypertensive medicines at the start of total diet replacement. The Counterweight-Plus programme provided about 3470 kJ/day (830 kcal) over 12-20 weeks, with automatic reductions in all nutrients including sodium, to produce rapid weight loss. Blood pressure was monitored regularly, with an antihypertensive reintroduction protocol based on current clinical guidelines. Outcomes were changes in blood pressure, antihypertensive prescriptions and symptoms during the initial total diet replacement phase.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Of 143 people who began total diet replacement, 78 (55%) were treated for hypertension at baseline. Overall mean blood pressure fell significantly from week 1 and was significantly lower at week 20, after total diet replacement finished, and at 12 and 24 months.
  2. 2
    Of the 78 previously treated, 65 (83%) stopped all antihypertensive and diuretic medicines per protocol and 4 (5%) stopped some. In these 69, blood pressure did not change in the first week but mean blood pressure fell significantly from week 9; no excessive rises were recorded in individuals.
  3. 3
    Even so, medicines were reintroduced for 19 of 69 (27.5%) to manage raised blood pressure, mostly within the first 3-7 weeks and despite some weight loss: 5 of the 19 had previously been on one drug and 14 on two or more. At 24 months, 19 (28%) of the 69 remained off medicines.
  4. 4
    Among 53 people in sustained diabetes remission at 24 months (mean weight loss 11.4 kg), 31 had been treated for hypertension; 27 stopped medicines at baseline and 15 of those 27 needed medicines reintroduced.
  5. 5
    Mild to moderate dizziness, suggesting some postural hypotension, was reported by 51 participants during total diet replacement; 15 of them had recorded dizziness at baseline, and 9 of those 15 were on antihypertensive or diuretic medicines.

Limits & uncertainty

  1. 1
    Post hoc analysis within one trial arm, with no comparison group in this analysis, so blood pressure changes cannot be separated from other effects of the programme.
  2. 2
    The abstract gives no blood pressure values in mm Hg, only that mean blood pressure fell significantly.
  3. 3
    Medicines were withdrawn inside a structured programme with regular blood pressure monitoring and a reintroduction protocol; results may not transfer to people who change medicines or diet on their own.
  4. 4
    The dizziness result is descriptive: 15 of the 51 people reporting it already had dizziness at baseline, and there is no control group to compare. This reading is based on the abstract only.

What to take from it

In this supervised programme, blood pressure fell as people lost weight, yet a good number of those who stopped their medicines needed some restarted; 14 of the 19 who needed a restart had been on two or more drugs. That shows the medicines question is individual and needs monitoring. Whether to change blood pressure medicines is a decision for the clinician who prescribes them, and this reading is not advice to stop or reduce your own. Dizziness during rapid weight loss is worth telling a clinician about.

Reading your own data

If you are losing weight under clinician guidance, a home cuff log is the data that matters: seated, rested readings at the same times each day, weekly averages rather than single numbers, and a note of any dizziness on standing. Log your weight beside it to see how the two move together, and take the log to appointments instead of adjusting medicines yourself.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Aims/hypothesis

Our aim was to evaluate the safety and efficacy of a planned therapeutic withdrawal of all antihypertensive and diuretic medications, on commencing a formula low-energy diet replacement, targeting remission of type 2 diabetes.

Methods

Post hoc analysis of changes in BP, antihypertensive medication prescriptions and symptoms during the initial total diet replacement phase was performed in the intervention arm of the Diabetes Remission Clinical Trial (n = 143) and in the subset (n = 69) who discontinued antihypertensive medications at the start of total diet replacement. The Counterweight-Plus total diet replacement provided about 3470 kJ/day (830 kcal) with automatic reductions in all nutrients, including sodium, to achieve marked negative energy balance and rapid weight loss over 12-20 weeks, with regular BP monitoring and an antihypertensive reintroduction protocol based on current clinical guidelines.

Results

Of 143 intervention group participants who commenced total diet replacement, 78 (55%) were on treatment for hypertension at baseline. The overall mean BP fell significantly from the start of total diet replacement (week 1) and was significantly lower at week 20, after total diet replacement finished, and also at 12 and 24 months. Of the 78 participants previously on treatment for hypertension, 65 (83%) stopped all antihypertensive and diuretic medications as per protocol, and four (5%) stopped some drugs. These 69 participants experienced no immediate (within the first week) change in BP, but their mean BP fell significantly from 9 weeks. No excessive rises in BP were recorded in individuals, but antihypertensive medications were reintroduced during total diet replacement to manage raised BP for 19/69 (27.5%) participants, mostly within the first 3-7 weeks, despite some weight loss. Reintroduction of antihypertensive medications was necessary for 5/19 participants previously on one drug, and for 14/19 previously on two or more drugs. Of the 69 who stopped antihypertensives, 19 (28%) remained off medications at 24 months. Among the 53 participants who achieved sustained remissions of diabetes at 24 months (with a mean weight loss of 11.4 kg), 31 had been previously treated for hypertension. Twenty-seven stopped medication at baseline, and 15/27 required reintroduction of antihypertensive medications. Mild to moderate dizziness, suggesting some postural hypotension, was reported during total diet replacement by 51 participants, 15 of whom had recorded dizziness at baseline prior to starting total diet replacement, with nine of these on antihypertensive or diuretic medications.

Conclusions/interpretation

Replacing antihypertensive medications with a 3470 kJ/day (830 kcal) diet to induce weight loss reduces BP substantially and may increase mild dizziness. It is safe to stop antihypertensives, but BP should be monitored regularly, particularly for those taking two or more antihypertensives, as over two-thirds will require reintroduction of some medications. Long-term support to maintain weight loss is vital.

Trial registration

ISRCTN registry, number 03267836.

Sources & attribution

Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT).

Leslie WS, Ali E, Harris L, Messow CM, Brosnahan NT, Thom G, McCombie EL, Barnes AC, Sattar N, Taylor R, Lean MEJ.

Diabetologia · 2021-05-31

DOI: 10.1007/s00125-021-05471-x ↗PubMed · 34056684 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

In-depth explainersRead study →
·Trial meta-analysis

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

In-depth explainersRead study →
·Randomised trial

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

In-depth explainersRead study →
·Validation study/review

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

In-depth explainersRead study →
Cardiovascular health →